Not So Different: A Podcast from The Center for Biosimilars
By Not So Different: a Podcast from The Center for Biosimilars
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Health & Fitness
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 157
Description
"Not So Different," a podcast from The Center for Biosimilars, brings you expert viewpoints from physicians, pharmacists, patients, developers, and other stakeholders in the complex world of biosimilar therapies.
| Episode | Date |
|---|---|
|
S7 Ep5: Follow the Science: Bridging the Biosimilar Gap
|
Jul 27, 2025 |
|
S7 Ep4: Escaping the Void: All Things Biosimilars With Craig & G
|
May 05, 2025 |
|
S7 Ep3: How AI Can Help Address Cost-Related Nonadherence to Biologic, Biosimilar Treatment
|
Mar 09, 2025 |
|
S7 Ep2: Will the FTC Be More PBM-Friendly Under A Second Trump Administration?
|
Feb 23, 2025 |
|
S7 Ep1: Biosimilars in Action: Market Shifts, Legal Insights, and FDA Approvals
|
Feb 09, 2025 |
|
S6 Ep41: The Top 5 Most-Listened to Podcasts of 2024
|
Dec 29, 2024 |
|
S6 Ep40: Biosimilars Gastroenterology Roundup for November 2024—Podcast Edition
|
Dec 01, 2024 |
|
S6 Ep39: Can Global Policies to Boost Biosimilar Adoption Work in the US?
|
Nov 17, 2024 |
|
S6 Ep38: Biosimilars Development Roundup for October 2024—Podcast Edition
|
Nov 03, 2024 |
|
S6 Ep37: Biosimilars Policy Roundup for September 2024—Podcast Edition
|
Oct 06, 2024 |
|
S6 Ep36: Biosimilars Business Roundup for August 2024—Podcast Edition
|
Sep 01, 2024 |
|
S6 Ep35: Biosimilars Policy Roundup for July 2024—Podcast Edition
|
Aug 04, 2024 |
|
S6 Ep34: Biosimilars in America: Overcoming Barriers and Maximizing Impact
|
Jul 21, 2024 |
|
S6 Ep33: Biosimilars Oncology Roundup for June 2024—Podcast Edition
|
Jul 07, 2024 |
|
S6 Ep32: Breaking Barriers in Osteoporosis Care: New Denosumab Biosimilars Wyost, Jubbonti Approved
|
Jun 16, 2024 |
|
S6 Ep31: Biosimilars Gastroenterology Roundup for May 2024—Podcast Edition
|
Jun 02, 2024 |
|
S6 Ep30: Insights from Festival of Biologics: Dracey Poore Discusses Cardinal Health’s 2024 Biosimilar Report
|
May 19, 2024 |
|
S6 Ep29: Biosimilars Policy Roundup for April 2024—Podcast Edition
|
May 05, 2024 |
|
S6 Ep28: Biosimilars Dermatology Roundup for March 2024—Podcast Edition
|
Mar 31, 2024 |
|
S6 Ep27: Decoding the Patent Puzzle: Navigating the Legal Landscape of Biosimilars
|
Mar 17, 2024 |
|
S6 Ep26: Biosimilars Rheumatology Roundup for February 2024—Podcast Edition
|
Mar 03, 2024 |
|
S6 Ep25: Exploring the Biosimilar Horizon: Julie Reed's Predictions for 2024
|
Feb 18, 2024 |
|
S6 Ep24: Biosimilars Gastroenterology Roundup for January 2024—Podcast Edition
|
Feb 04, 2024 |
|
S6 Ep23: A New Chapter: How 2023 Will Shape the US Biosimilar Space for 2024 and Beyond
|
Dec 31, 2023 |
|
S6 Ep22: The Subcutaneous Revolution: Zymfentra and the Future of IBD Care With Dr Andres Yarur
|
Dec 17, 2023 |
|
S6 Ep21: Biosimilar Oncology Roundup for November 2023—Podcast Edition
|
Dec 03, 2023 |
|
S6 Ep20: Global Biosimilars Week: Dr Fran Gregory Explores the Growing Oncology Biosimilar Space, Previews Future
|
Nov 19, 2023 |
|
S6 Ep19: Biosimilar Business Roundup for October 2023—Podcast Edition
|
Nov 05, 2023 |
|
S6 Ep18: Biosimilars Regulatory Roundup For September 2023– Podcast Edition
|
Oct 02, 2023 |
|
S6 Ep17: Dr. Fran Gregory's Sizes Up the US Adalimumab Market: Will Biosimilars See Success?
|
Sep 17, 2023 |
|
S6 Ep16: Biosimilars Business Roundup For August 2023– Podcast Edition
|
Sep 03, 2023 |
|
S6 Ep15: How Streamlining Development Can Save the US Biosimilar Industry
|
Aug 20, 2023 |
|
S6 Ep14: Biosimilars Immunology Roundup for July 2023- Podcast Edition
|
Aug 06, 2023 |
|
S6 Ep13: Adalimumab Biosimilars Take Center Stage: A Game Changer for IBD Treatment
|
Jul 16, 2023 |
|
S6 Ep12: Biosimilars Business Roundup for June 2023—Podcast Edition
|
Jul 02, 2023 |
|
S6 Ep11: Biosimilars Immunology Roundup for May 2023—Podcast Edition
|
Jun 04, 2023 |
|
S6 Ep10: What AmerisourceBergen's Report Reveals About Payers, Biosimilar Pricing Trends
|
May 28, 2023 |
|
S6 Ep9: Dr. Vibeke Strand: The Current State of Immunology Biosimilars and the Promise of Future Savings
|
May 14, 2023 |
|
S6 Ep8: Biosimilars Rheumatology Roundup for April 2023—Podcast Edition
|
Apr 30, 2023 |
|
S6 Ep7: Pipelines and Preparation: How the US Can Prepare for More RA Biosimilars
|
Apr 16, 2023 |
|
S6 Ep6: Biosimilars Policy Roundup for March 2023—Podcast Edition
|
Apr 02, 2023 |
|
S6 Ep5: How Community Oncologists Can Break Down Biosimilar Adoption Barriers
|
Mar 19, 2023 |
|
S6 Ep4: Biosimilars Gastroenterology Roundup for February 2023—Podcast Edition
|
Mar 05, 2023 |
|
S6 Ep3: On the Come Up: What Vizient’s Report Says About Inflation and Biosimilars
|
Feb 26, 2023 |
|
S6 Ep2: Biosimilars Rheumatology Roundup for January 2023—Podcast Edition
|
Feb 05, 2023 |
|
S6 Ep1: Seeing Eye to Eye: FDA's Dr Sarah Yim Discusses Efforts to Increase Confidence in Ophthalmology Biosimilars
|
Jan 29, 2023 |
|
S5 Ep14: Goodbye 2022—The Top 10 Biosimilars Stories of the Year
|
Jan 01, 2023 |
|
S5 Ep13: New Year, New Hurdles: What's in Store for Biosimilars in 2023
|
Dec 18, 2022 |
|
S5 Ep12: Biosimilars Regulatory Roundup for November 2022—Podcast Edition
|
Dec 04, 2022 |
|
S5 Ep11: What Amgen’s Biosimilar Trends Report Says About the Future of Biosimilars
|
Nov 27, 2022 |
|
S5 Ep10: AAM's Craig Burton: Is the Biden Administration Doing Enough to Help Biosimilars?
|
Nov 13, 2022 |
|
S5 Ep10: Biosimilars Policy Roundup for October 2022—Podcast Edition
|
Nov 06, 2022 |
|
S5 Ep9: Order of Operations: Managing Biosimilars While Maintaining Operational Efficiency
|
Oct 16, 2022 |
|
S5 Ep8: Biosimilars Oncology Roundup for September 2022—Podcast Edition
|
Oct 02, 2022 |
|
S5 Ep7: How Heath Policy Can Impact Adoption for Adalimumab Biosimilars
|
Sep 25, 2022 |
|
S5 Ep6: What Will Year 1 Look Like for Adalimumab Biosimilars?
|
Sep 11, 2022 |
|
S5 Ep5: Biosimilars Regulatory Roundup for August 2022—Podcast Edition
|
Sep 04, 2022 |
|
S5 Ep4: Tools of the Trade: How McKesson’s Intrafusion Improves Infusion Center Efficiency, Biosimilar Utilization
|
Aug 21, 2022 |
|
S5 Ep3: Not So Different: Biosimilars Oncology Roundup for July 2022—Podcast Edition
|
Aug 07, 2022 |
|
S5 Ep2: How Health Policies May Take Shape in a Post-Humira-Exclusive Adalimumab Market
|
Jul 24, 2022 |
|
S5 Ep1: Dr. Sonia Oskouei Discusses the US Launch of Byooviz, the First Ophthalmology Biosimilar
|
Jul 10, 2022 |
|
S4 Ep22: Not So Different: Tactics for Increasing Patient and Provider Confidence in Biosimilars
|
Oct 10, 2021 |
|
S4 Ep21: Not So Different: How 1 Practice is Addressing Biosimilar Concerns Over Savings, Safety, and Efficacy
|
Oct 03, 2021 |
|
S4 Ep20: Not So Different: How Biosimilar Companies Are Stepping Up Their Game to Compete Against Originators
|
Sep 19, 2021 |
|
S4 Ep19: Not So Different: Gary Lyman, MD Details What Needs to Be Done to Ensure Physician Confidence in Biosimilars
|
Aug 15, 2021 |
|
S4 Ep18: Not So Different: Should Biosimilar Variations Be Concerning?
|
Aug 01, 2021 |
|
S4 Ep17: Not So Different: What the Generics Industry Can Tell Us About the Future of Biosimilars
|
Jul 18, 2021 |
|
S4 Ep16: Not So Different: Axinn Patent Litigator Discusses Implications of ACA Ruling
|
Jul 04, 2021 |
|
S4 Ep15: Not So Different: How Henlius is Making Its Mark on the Global Biosimilar Industry
|
Jun 20, 2021 |
|
S4 Ep14: How Pharmacists Can Help Boost Biosimilar Uptake
|
May 23, 2021 |
|
S4 Ep13: The Fight to Align Payer Preferences With Community Oncology
|
May 09, 2021 |
|
S4 Ep12: What’s Stopping Physicians From Prescribing Biosimilars?
|
Apr 25, 2021 |
|
S4 Ep11: How to Improve Perception Hurdles to Biosimilar Adoption
|
Apr 11, 2021 |
|
S4 Ep10: Has Brexit Hindered Biosimilar Development?
|
Apr 04, 2021 |
|
S4 Ep9: Dr Juliette Petit: How Nurses Prevent Nocebo Effect in Biosimilar Switching
|
Mar 28, 2021 |
|
S4 Ep8: Minnesota Legislator Discusses Bill to Broaden Biosimilar Coverage
|
Mar 14, 2021 |
|
S4 Ep7: Goodwin Attorneys Discuss Updates to Biosimilars Litigation Guide
|
Mar 07, 2021 |
|
S4 Ep6: Anar Dossa Discusses Success and Savings With British Columbia’s Biosimilars Initiative
|
Feb 28, 2021 |
|
S4 Ep5: Sarfaraz Niazi, PhD Discusses Market Projections For High-Concentration Adalimumab Biosimilars
|
Feb 21, 2021 |
|
S4 Ep4: Steven Lucio Discusses BI’s Citizen Petition and the Current Status of Biosimilars
|
Feb 14, 2021 |
|
S4 Ep3: The Race to the Top: Does China Have What it Takes?
|
Feb 07, 2021 |
|
S4 Ep2: Why You Should Keep Your Eye on Ophthalmology Biosimilars
|
Jan 24, 2021 |
|
S4 Ep1: Charles Bennett, MD, PhD, Discusses Why the FTC Needs to Join the Effort to Improve the Biosimilar Market
|
Jan 10, 2021 |
|
S3 Ep32: Sean McGowan on What’s in Store for Biosimilars in 2021 and Beyond
|
Dec 06, 2020 |
|
S3 Ep31: A Trio of Experts’ Take on What Needs to Change to Boost Biosimilar Adoption
|
Nov 29, 2020 |
|
S3 Ep30: Kathy Oubre On What Practices Can Learn About the Benefits of Implementing Biosimilars
|
Nov 15, 2020 |
|
S3 Ep29: Steven C. Hill, PhD, Discusses Rebates and Specialty Drug Spending
|
Nov 08, 2020 |
|
S3 Ep28: Nancy Globus, PharmD, on Whether Comparative Efficacy Trials are Necessary
|
Oct 25, 2020 |
|
S3 Ep27: Kathy Oubre on What Oncology Practices Lacked During the Pandemic
|
Oct 18, 2020 |
|
S3 Ep26: Kanika Monga, MD, and Angus Worthing, MD, Discuss ACR Survey on Biosimilars and COVID-19
|
Oct 11, 2020 |
|
S3 Ep25: Wayne Winegarden, PhD, On Why Importing Drugs From Canada Is a Bad Idea
|
Oct 04, 2020 |
|
S3 Ep24: Julie Kennerly-Shah, PharmD, on How Biosimilars Can Help Curb COVID-19's Impact
|
Sep 27, 2020 |
|
S3 Ep23: Rep Grothman on His Bill to Make Biosimilar Insulins Interchangeable
|
Sep 20, 2020 |
|
S3 Ep22: Alex Moulson on How Companies Choose Which Biosimilars to Produce
|
Sep 13, 2020 |
|
S3 Ep21: Cheryl Larson on How Employers Can Get Biosimilars Added to Their Health Plan
|
Sep 06, 2020 |
|
S3 Ep20: Jonathan Sweeting on Aybintio's European Approval
|
Aug 30, 2020 |
|
S3 Ep19: Nancy Globus, PharmD, on the Effect of Biosimilar Suffixes
|
Aug 23, 2020 |
|
S3 Ep18: Carter Thorne, MD, Discusses Biosimilar Switching in Canada
|
Aug 16, 2020 |
|
S3 Ep17: Sizing Up European Biosimilar Competition
|
Aug 09, 2020 |
|
S3 Ep16: Dorothy McCabe, PhD, Discusses How to Combat Biosimilar Misinformation
|
Aug 02, 2020 |
|
S3 Ep15: Rathore: What Biosimilar Developers Can Learn From Application Failures
|
Jul 26, 2020 |
|
S3 Ep14: Byoungseo Choi on Celltrion's Biosimilar Goals For 2030
|
Jul 19, 2020 |
|
S3 Ep13: Ryan Haumschild, PharmD, Discusses Plan to Increase Biosimilar Utilization
|
Jul 12, 2020 |
|
S3 Ep12: Dr Jing Chao Discusses Knowledge Gaps and the Future for Biosimilar Insulins
|
Jul 05, 2020 |
|
S3 Ep11: Joe Fuhr, PhD Discusses His Predictions for the Growing Biosimilar Market
|
Jun 28, 2020 |
|
S3 Ep10: Nick Mitrokostas Discusses New Biosimilar Approval and Outlooks for 2020
|
Jun 21, 2020 |
|
S3 Ep9: Christine Simmon Discusses AAM Efforts for Biosimilar Legislation
|
Jun 14, 2020 |
|
S3 Ep8: Biosimilar Law Experts Discuss Potential Bills and Chances for Passage
|
Jun 07, 2020 |
|
S3 Ep7: April Breyer Menon Discusses 2 Potential Bills to Aid Biosimilar Uptake
|
May 28, 2020 |
|
S3 Ep6: Noelle Sunstrom and the Potential Growth for NeuClone
|
May 24, 2020 |
|
S3 Ep5: Dr Sang-Jin Pak Talks Biosimilar Market Stability
|
May 03, 2020 |
|
S3 Ep4: Dr. Sang-Jin Pak Talks Biosimilar Markets: US vs Europe
|
Apr 25, 2020 |
|
S3 Ep3: "Not So Different": How the BPCIA Transition Will Impact Biosimilar Uptake
|
Apr 09, 2020 |
|
S3 Ep2: Employers Advocate for Lower Drug Costs Through Biosimilars
|
Jan 13, 2020 |
|
S3 Ep1: Goodwin Attorneys Give a Look at Biosimilar Litigation
|
Jan 05, 2020 |
|
S2 Ep32: The Year in US Regulatory Activity for Biosimilars
|
Dec 29, 2019 |
|
S2 Ep31: At the American College of Rheumatology, a UK Perspective on Biosimilars
|
Dec 22, 2019 |
|
S2 Ep30: AmerisourceBergen’s Sean McGowan Takes a Closer Look at US Biosimilar Launches
|
Dec 15, 2019 |
|
S2 Ep29: Celltrion Breaks New Ground With a Subcutaneous Biosimilar Infliximab
|
Dec 08, 2019 |
|
S2 Ep28: Biosimilar Business Updates From the Month of November
|
Dec 01, 2019 |
|
S2 Ep27: Is There a Role for Biosimilars in Value-Based Models?
|
Nov 24, 2019 |
|
S2 Ep26: HealthyWomen Wants to Educate US Women About Biosimilars
|
Nov 17, 2019 |
|
S2 Ep25: AARP Says High Prescription Drug Prices Will Impact All Americans
|
Nov 10, 2019 |
|
S2 Ep24: What's New in Biosimilars in Gastroenterology
|
Nov 03, 2019 |
|
S2 Ep23: Strategies for Biosimilar Developers in a Litigious US Landscape
|
Oct 27, 2019 |
|
S2 Ep22: Are We Ready for Biosimilar Rituximab in the United States?
|
Oct 20, 2019 |
|
S2 Ep21: What Have We Learned So Far About US Oncology Biosimilars?
|
Oct 13, 2019 |
|
S2 Ep20: OneOncology Gives a Closer Look at Its Biosimilar Adoption
|
Sep 29, 2019 |
|
S2 Ep19: Where Are We Headed With Oncology Biosimilars? Vizient Weighs In
|
Sep 15, 2019 |
|
S2 Ep18: How a Value-Based Pathway Led to Increased Biosimilar Use
|
Sep 01, 2019 |
|
S2 Ep17: What's Next for Drug Pricing After Withdrawal of the Rebate Rule?
|
Aug 18, 2019 |
|
S2 Ep16: The Biosimilars Council Says Patent Abuses Are Costing Biosimilar Savings
|
Aug 04, 2019 |
|
S2 Ep15: What Did the First Half of 2019 Hold for Biosimilars?
|
Jul 19, 2019 |
|
S2 Ep14: The Biosimilars Forum Wants to Save the Healthcare System Billions
|
Jul 07, 2019 |
|
S2 Ep13: What's Holding Back Biosimilars? It May Not Be Pay-for-Delay Deals
|
Jun 23, 2019 |
|
S2 Ep12: A Regulatory Attorney Shares His Take on Interchangeability
|
Jun 09, 2019 |
|
S2 Ep11: A Look Ahead to Biosimilar Insulin
|
May 26, 2019 |
|
S2 Ep10: A Look at Biosimilar Education Among European Oncologists
|
May 12, 2019 |
|
S2 Ep9: Is It Time to Give Up On Biosimilars?
|
Apr 28, 2019 |
|
S2 Ep8: Drug Pricing in the United States: a Conversation with Robin Feldman
|
Apr 14, 2019 |
|
S2 Ep7: The Community Oncology Perspective on Drug Pricing Proposals and Biosimilars
|
Mar 31, 2019 |
|
S2 Ep6: Addressing Misinformation on Biosimilars
|
Mar 23, 2019 |
|
S2 Ep5: Meet the Nonprofit Taking on Generic Drug Shortages
|
Mar 09, 2019 |
|
S2 Ep4: "Not so Different:" The Supreme Court and US Biosimilars
|
Feb 22, 2019 |
|
S2 Ep3: Where Do We Stand With Provider Education on Biosimilars?
|
Feb 08, 2019 |
|
S2 Ep2: How Biosimilars Advanced in 2018
|
Jan 25, 2019 |
|
S2 Ep1: What’s New in Biosimilar Regulation?
|
Aug 17, 2018 |
|
Episode 10: The Patient Perspective on Biosimilars
|
Jun 03, 2018 |
|
Episode 9: Biosimilars and Expanded Access to Cancer Treatment
|
May 20, 2018 |
|
Episode 8: Medicare and Biosimilars
|
May 06, 2018 |
|
Episode 7: Oncology Biosimilars
|
Apr 22, 2018 |
|
Episode 6: The Nebraska Rheumatology Society
|
Apr 05, 2018 |
|
Episode 5: Policy and Biosimilars
|
Mar 20, 2018 |
|
Episode 4: Creating a Vibrant Biosimilars Market
|
Mar 16, 2018 |
|
Episode 3: Pricing
|
Mar 02, 2018 |
|
Episode 2: Nonmedical Switching
|
Feb 14, 2018 |
|
Episode 1: Interchangeability
|
Feb 02, 2018 |